Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common barriers to exercise and how may we overcome them?

Blue Monday originated from a publicity stunt, but seasonal affective disorder is a real affliction that affects millions of people. There are ways to treat it.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good thing? And is depression weight loss even a thing in the first place?

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

Inauguration Day in photos, the allure of coffee shops, how to handle seasonal depression: Catch up on the day’s stories Editor’s Note: CNN’s 5 Things newsletter is your one-stop shop for the latest headlines and fascinating stories to start and end your busy day. Sign up here.

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

Depression is a complex disorder that affects people in various ways, influencing mood, thoughts, behavior, and even physical functioning. It’s important to pause and reflect on how this disorder impacts diverse communities – particularly the Latino population in Indianapolis.

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

Investigators found negative mental health conditions among women firefighters may reduce levels of key hormone associated with ovarian reserve.